Health
FDA approves Rasonque for metastatic pancreatic cancer
The US Food and Drug Administration has approved Rasonque, an oral drug by Revolution Medicines for adults with metastatic pancreatic adenocarcinoma.
Bringing you stories that vibe with your fashion
